CXCL10 and lung carcinoma: In our previous studies, we found that the adaptive immunity which against lung carcinoma can be activated by pyroptotic lung cancer cells, which lead to significant increase of IFN-γ, IP-10, MIP-1α, MIP-1β, MIP-2, and TNF-α [6].